PROCEPT BioRobotics (PRCT) director receives new RSU and stock option grants
Rhea-AI Filing Summary
PROCEPT BioRobotics director Thomas M. Prescott received new equity awards in the form of restricted stock units and stock options. He was granted 3,315 restricted stock units, each representing a right to receive one share of Common Stock, and now holds 7,211 shares of Common Stock following the award. The RSUs vest in full on the earlier of the one-year anniversary of the June 9, 2026 grant date or the next annual meeting, subject to continued service.
He was also granted stock options for 5,853 shares of Common Stock at an exercise price of $28.78 per share, vesting on the same schedule and expiring on June 8, 2036. These are compensation-related grants rather than open‑market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 5,853 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 3,315 | $0.00 | $0.00 |
Footnotes (2)
- F1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
- F2. The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Key Figures
Key Terms
restricted stock units (RSUs) financial
Stock option (Right to Buy) financial
exercise price financial
expiration date financial
annual meeting financial
AI-generated analysis. How Rhea-AI works. Not financial advice.